Trial intelligence / Profile preview

Niaoqingshu granules plus tamsulosin vs tamsulosin for chronic prostatitis/chronic pelvic pain syndrome

ChiCTR2500108889Phase 4Completed

Sponsor
The First Affiliated Hospital of Sun Yat-sen University
Start
Sep 2025
Countries
1
01

Overview

Phase 4, open-label trial of niaoqingshu in chronic prostatitis (CP) (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI). Started Sep 2025; status: completed.

02

Drugs

niaoqingshu
03

Conditions

chronic prostatitis (CP)

Beyond the preview

Go deeper on ChiCTR2500108889.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500108889.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call